微生物与感染
2024年11月28日 星期四   首页 |  主编心语 |  期刊介绍 |  编委阵容 |  投稿指南 |  出版道德 |  期刊订阅 |  联系我们 | English
微生物与感染  2017, Vol. 12 Issue (6): 385-390    
  综述 本期目录 | 过刊浏览 | 高级检索 |
金黄色葡萄球菌杀白细胞素ED的研究进展
杨涵,刘庆中
上海交通大学附属第一人民医院检验医学中心,上海 200080
Research updates on leukocidin ED of Staphylococcus aureus
YANG Han, Liu Qingzhong
Department of Clinical Laboratory, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
全文: PDF (547 KB)   HTML (0)
输出: BibTeX | EndNote (RIS)      
摘要: 杀白细胞素ED(leukocidin ED,LukED)是金黄色葡萄球菌产生的双组分成孔杀白细胞素之一,由共转录于一条mRNA的lukElukD两个基因编码。LukED可与趋化因子受体CCR5结合以杀伤巨噬细胞、T细胞和树突细胞,或与中性粒细胞、单核细胞和自然杀伤(natural kiler,NK)细胞上的表面受体CXCR1/2结合以促进金黄色葡萄球菌的致病性及系统性感染宿主的死亡。此外,LukED还可结合Duffy 抗原趋化因子受体,使裂解红细胞释放血红蛋白,促进细菌的铁吸收和生长繁殖。LukED的表达受双组分信号转导系统附属基因调节子——毒素抑制子(Agr-Rot)通路和转录调节子RpiRc、SpoVG的调控。lukED基因在金黄色葡萄球菌中广泛流行,与金黄色葡萄球菌所致血流感染、脓疱病及抗生素相关性腹泻密切相关。这些进展对了解LukED的表达调控机制、临床意义及其在细菌致病机制中的作用,开发新的金黄色葡萄球菌感染抗毒素治疗药物具有重要意义

服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
杨涵
刘庆中
关键词 金黄色葡萄球菌毒力因子杀白细胞素ED抗毒素治疗    
Abstract:As a member of bicomponent pore-forming leucocidins from Staphylococcus aureus (S. aureus), leukocidin ED (LukED) is encoded by two linked genes (lukE and lukD), which are co-transcribed into one mRNA. LukED is found to be able to target the chemokine receptor CCR5 to kill inflammatory macrophages, T cells, and dendritic cells, or to target receptor CXCR1/2 on neutrophils, monocytes and natural killer (NK) cells to enhance pathogenicity of S. aureus and death of the host. In addition, LukED can also lyse erythrocytes to release hemoglobin by binding to the Duffy antigen receptor for chemokines, and further promote the absorption of iron and growth of bacteria. The expression of LukED is regulated by the accessory gene regulatory-repressor of toxins (agr-rot) pathway and transcriptional regulators such as RpiRc and SpoVG. Studies show that lukED genes have a high frequency in S. aureus and have a close association with bloodstream infection, impetigo and antibiotic-associated diarrhea. Progress on researches of LukED not only improves our knowledge about clinical importance and the pathogenesis of S. aureus, but also provides insight into the development of potential novel anti-toxin drugs for the treatment of S. aureus infection.

Key wordsStaphylococcus aureus    Virulence factor    Leukocidin ED    Anti-toxin therapy
基金资助:国家自然科学基金(81371872),上海市自然科学基金(12ZR1425000)

通讯作者: 刘庆中   
引用本文:   
杨涵,刘庆中. 金黄色葡萄球菌杀白细胞素ED的研究进展[J]. 微生物与感染, 2017, 12(6): 385-390.
YANG Han, Liu Qingzhong. Research updates on leukocidin ED of Staphylococcus aureus. JOURNAL OF MICROBES AND INFECTIONS, 2017, 12(6): 385-390.
链接本文:  
http://jmi.fudan.edu.cn/CN/     或     http://jmi.fudan.edu.cn/CN/Y2017/V12/I6/385

版权所有 © 2008 《微生物与感染》编辑部
地址:上海市医学院路138号 邮编:200032
Tel:021-54237633 Fax:021-64434224    E-mail:jmi@fudan.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发  技术支持:support@magtech.com.cn